Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Novo Integrated Sciences Inc (NVOS)

Novo Integrated Sciences Inc (NVOS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Novo Integrated Sciences Inc 11120 NE 2ND STREET SUITE 100 BELLEVUE WA 98004 USA

www.novointegrated.com Employees: 264 P: 206-617-9797

Description:

Novo Integrated Sciences Inc. is a provider of multi-dimensional primary healthcare services and products principally in Canada and the U.S. It deliver or intend to deliver, multidisciplinary primary health care related services and products through the integration of medical technology, advanced therapeutics and rehabilitative science, through its subsidiaries. Novo Integrated Sciences Inc. is based in Bellevue, Washington.

Key Statistics

Overview:

Market Capitalization, $K 789
Enterprise Value, $K 1,629
Shares Outstanding, K 19,730
Annual Sales, $ 12,570 K
Annual Net Income, $ -13,210 K
Last Quarter Sales, $ 3,150 K
Last Quarter Net Income, $ -13,740 K
EBIT, $ -10,470 K
EBITDA, $ -3,410 K
60-Month Beta -1.89
% of Insider Shareholders 10.40%
% of Institutional Shareholders 5.67%
Float, K 17,678
% Float 89.60%
Short Volume Ratio 0.27

Growth:

1-Year Return -96.49%
3-Year Return -99.71%
5-Year Return -99.92%
5-Year Revenue Growth 41.39%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings 0.31 on 12/18/24
Next Earnings Date 01/27/25
Earnings Per Share ttm -1.18
EPS Growth vs. Prev Qtr 141.89%
EPS Growth vs. Prev Year -86.53%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 1-10 on 11/07/23

NVOS Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -93.07%
Return-on-Assets % -46.28%
Profit Margin % -105.09%
Debt/Equity 0.11
Price/Sales 0.06
Price/Cash Flow N/A
Price/Book 0.04
Book Value/Share 0.51
Interest Coverage -35.86
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar